Saman Sotoudeh-Paima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saman Sotoudeh-Paima has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ehsan Abadi
Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University School of Medicine, 2424 Erwin Rd, Hock Plaza, Ste 302, Durham, NC 27705
1 shared publication - Ehsan Samei
Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology, Duke University School of Medicine, 2424 Erwin Rd, Hock Plaza, Ste 302, Durham, NC 27705
1 shared publication - Fakrul Islam Tushar
Duke Univ. (United States)
1 shared publication - Joseph Y. Lo
Duke University
1 shared publication - Lavsen Dahal
Duke University
1 shared publication - William Paul Segars
Duke University
1 shared publication
Latest Publications
- 1 January 2026
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 13 (01) , 1-16
Utility of the virtual imaging trials methodology for objective characterization of AI systems and training data
PurposeThe credibility of artificial intelligence (AI) models for medical imaging continues to be a challenge, affected by the diversity of models, the data used to train the models, and the applicability of their combination to produce reproducible results for new data. We aimed to explore whether emerging virtual imaging trial (VIT) methodologies can provide an objective resource to approach this challenge.ApproachWe conducted this study for the case example of COVID-19 diagnosis using clinical and virtual computed tomography (CT) and chest radiography (CXR) processed with convolutional neural networks. Multiple AI models were developed and tested using 3D ResNet-like and 2D EfficientNetv2 architectures across diverse datasets.ResultsModel performance was evaluated using the area under the curve (AUC) and the DeLong method for AUC confidence intervals. The models trained on the most diverse datasets showed the highest external testing performance, with AUC values ranging from 0.73 to 0.76 for CT and 0.70 to 0.73 for CXR. Internal testing yielded higher AUC values (0.77 to 0.85 for CT and 0.77 to 1.0 for CXR), highlighting a substantial drop in performance during external validation, which underscores the importance of diverse and comprehensive training and testing data. Most notably, the VIT approach provided an objective assessment of the utility of diverse models and datasets while offering insight into the influence of dataset characteristics, patient factors, and imaging physics on AI efficacy.ConclusionsThe VIT approach enhances model transparency and reliability, offering nuanced insights into the factors driving AI performance and bridging the gap between experimental and clinical settings.
- 1 January 2026
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 13 (01) , 1-16
Utility of the virtual imaging trials methodology for objective characterization of AI systems and training data
PurposeThe credibility of artificial intelligence (AI) models for medical imaging continues to be a challenge, affected by the diversity of models, the data used to train the models, and the applicability of their combination to produce reproducible results for new data. We aimed to explore whether emerging virtual imaging trial (VIT) methodologies can provide an objective resource to approach this challenge.ApproachWe conducted this study for the case example of COVID-19 diagnosis using clinical and virtual computed tomography (CT) and chest radiography (CXR) processed with convolutional neural networks. Multiple AI models were developed and tested using 3D ResNet-like and 2D EfficientNetv2 architectures across diverse datasets.ResultsModel performance was evaluated using the area under the curve (AUC) and the DeLong method for AUC confidence intervals. The models trained on the most diverse datasets showed the highest external testing performance, with AUC values ranging from 0.73 to 0.76 for CT and 0.70 to 0.73 for CXR. Internal testing yielded higher AUC values (0.77 to 0.85 for CT and 0.77 to 1.0 for CXR), highlighting a substantial drop in performance during external validation, which underscores the importance of diverse and comprehensive training and testing data. Most notably, the VIT approach provided an objective assessment of the utility of diverse models and datasets while offering insight into the influence of dataset characteristics, patient factors, and imaging physics on AI efficacy.ConclusionsThe VIT approach enhances model transparency and reliability, offering nuanced insights into the factors driving AI performance and bridging the gap between experimental and clinical settings.